Posts in tag

Maxigesic


Hikma Pharmaceutical’s first sale of Maxigesic IV in the US delivers boost for AFT Pharmaceuticals  AFT Pharmaceuticals – the owner of the Maxigesic ibuprofen/paracetamol combination drug – has raised its …

Flagship Maxigesic products and Australian OTC business contribute the most to latest half yearly results Maxigesic manufacturer AFT Pharmaceuticals has reported higher bottom-line profit and revenue after continued robust demand …

Kiwi Maxigesic owner posts $NZD20m profit boosted by licensing income  AFT Pharmaceuticals, the New Zealand-headquartered outfit best known for its Maxigesic ibuprofen/paracetamol combination, will pay its first dividend in its …

Kiwi pharmaco behind Maxigesic sees net profits down 2/3 year-on-year but leadership remains upbeat about the future Lower licencing income and increased growth in spending were factors which saw the …

NZ company wins appeal in Maxigesic comparative advertising case AFT Pharmaceuticals has been victorious in its marathon legal battle with Nuromol producer Reckitt Benckiser to declare in advertising that its …

The pharmaceutical company has also seen a 16% growth in revenue, as it launches Maxigesic across several countries AFT Pharmaceuticals has announced its full-year audited financial results for the year …

Maxigesic is outselling other paracetamol-ibuprofen brands in pharmacy There has been strong sales in schedule 3 30s packs, which the company says is significant as it means pharmacists are recommending it …

Maxigesic has revealed their ‘Chance to win $1 Million’ winner – but how much did the lucky 19-year-old win? Tayla Laverty, 19, from Prospect in Tasmania, was drawn as a …

On Monday May 16 at 12pm one pharmacist has a one in 100 chance of becoming a Maxigesic Millionaire. The trade promotion was open to all Australian pharmacists over the …